Butylphthalide：Treating Stroke Nerve Damage

Butylphthalide：Treating Stroke Nerve Damage

Products

Information

CAS：6066-49-5 Molecular formula：C12H14O2 Formula weight：190.24 Appearance: Transparent to light yellow clarified oily liquid (API); Transparent liquid (injection) Indication： Improve the neurological deficits in patients with acute ischemic stroke. Improve the blood circulation of the brain, especially the micro-circulation in the ischemic area, has a relatively strong improvement effect. Protects neuronal mitochondrial function, improves energy metabolism and inhibits apoptosis.
Jilin Qijian Bio-pharmaceutical Co., LtdEstablished in 2004, Jilin Qijian Bio-Pharmaceutical Co., Ltd. is a cGMP pharmaceutical company and specialized in R&D, production and sales of API and FDF. Qijian is a High Tech Enterprise based in Changchun City, Jilin Province, China, and registered in US FDA, also filed in US FDA DMF. As manufacturer and global exporter, Qijian main products: Recombinant human growth hormone Somatropin (r-hGH ) （China GMP） Butylphthalide（China GMP） Ademetionine 1,4-Butanedisulfonate (SAM) Monosialotetrahexosyl-ganglioside Sodium (GM1)

Log in

See all the content and easy-to-use features by logging in or registering!